Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesia Comparison for Total Shoulder Arthroplasty
NCT02876055Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in postoperative pain (3 arms), sponsored by Mayo Clinic. Primary endpoint: Overall Benefit of Analgesia Score. Started Nov 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02876055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02876055.